![Kenneth Mills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Mills
Fondateur chez
REGENXBIO INC.
Fortune : 5 M $ au 31/07/2026
Profil
Kenneth T.
Mills is the founder of REGENXBIO, Inc., founded in 2008, serving as Chairman since 2024.
Mr. Mills is currently Chief Executive Officer & Director at Tagworks Pharmaceuticals BV since 2024.
Former positions include Director-Business Development at IGEN International, Inc. from 1997 to 2003, Chief Financial Officer & VP-Business Development at Meso Scale Diagnostics LLC from 2004 to 2006, and Partner at FoxKiser LLP from 2007 to 2015.
Education includes an undergraduate degree from the Massachusetts Institute of Technology, conferred in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REGENXBIO, INC. 0,76 % | 29/05/2026 | 495 925 ( 0,76 % ) | 5 M $ | 31/07/2026 |
Postes actifs de Kenneth Mills
| Sociétés | Poste | Début |
|---|---|---|
| REGENXBIO INC. | Fondateur | 16/07/2008 |
Tagworks Pharmaceuticals BV
 Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Develops biotechnology | Directeur Général | 01/10/2024 |
Anciens postes connus de Kenneth Mills
| Sociétés | Poste | Fin |
|---|---|---|
FOXKISER LLP
 FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services Provides strategic advice and counseling services | Corporate Officer/Principal | 01/01/2015 |
Meso Scale Diagnostics LLC
 Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Develops and markets solutions for multiplex biological assays | Directeur Financier/CFO | 01/12/2006 |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Corporate Officer/Principal | 01/12/2003 |
Formation de Kenneth Mills
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Meso Scale Diagnostics LLC
Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Develops and markets solutions for multiplex biological assays | Health Technology |
FOXKISER LLP
FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services Provides strategic advice and counseling services | Commercial Services |
Tagworks Pharmaceuticals BV
Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Develops biotechnology | Health Technology |
